Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 31, 2015 2:44 AM ET

Pharmaceuticals

Company Overview of Actavis Pharma, Inc.

Executive Profile

Paul M. Feuerman

Former General Counsel, Axonyx Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

54--

Background

Mr. Paul M. Feuerman was the General Counsel of Axonyx Inc. since June 2005. Mr. Feuerman served as General Counsel of TorreyPines Therapeutics, Inc. since October 3, 2006. Mr. Feuerman is a founding member of PharmAdvisors LLC. he was the Executive Vice President - Corporate Affairs, Secretary, General Counsel and Director at Actavis Pharma Inc. Previously, Mr. Feuerman was associated with the law firm of Proskauer Rose LLP. Mr. Feuerman has been a Director of Watson ...

Corporate Headquarters

Morris Corporate Center III
Parsippany, New Jersey 07054

United States

Phone: 877-698-5383
Fax: --

Board Members Memberships

1997-N/A
Executive Vice President - Corporate Affairs, Secretary, General Counsel and Director

Education

JD
School Of Law, Columbia University
BA
Trinity College
BA
Trinity College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Actavis Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.